Phoenix Asia Closes $6.4 Million IPO-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Phoenix Asia Closes $6.4 Million IPO

May 25, 2025 9:58 PM

04:19 AM EDT, 04/29/2025 (MT Newswires) -- Phoenix Asia Holdings ( PHOE ) said late Monday it closed its initial public offering of 1.6 million shares at $4 each, for $6.4 million in gross proceeds.

The Hong Kong-focused substructure contractor granted a 45-day overallotment option to the underwriters to acquire up to 240,000 additional shares.

Phoenix Asia ( PHOE ) said it plans to use the proceeds for hiring, acquisitions and working capital and other general corporate purposes.

Its shares started trading on Nasdaq Capital Market under the ticker symbol PHOE Friday.

Previous page： Bristol Myers posts quarterly loss, revenue rises 5% Next page： Merck raises 2024 profit forecast on strong cancer, HPV drugs sales

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bristol Myers posts quarterly loss, revenue rises 5%

Apr 25, 2024

April 25 (Reuters) - Bristol Myers Squibb ( BMY ) on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics offset a 5% increase in revenue. The New Jersey-based drugmaker posted a loss of $4.40 per share, including charges for acquired research and development. Analysts on average had expected a...

Merck raises 2024 profit forecast on strong cancer, HPV drugs sales

Apr 25, 2024

April 25 (Reuters) - Merck & Co ( MRK ) on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous prediction of $8.44 to $8.59,...

Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised

Apr 25, 2024

07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago. Analysts polled by Capital IQ expected $1.92. Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier. Analysts surveyed by Capital IQ expected $15.20 billion. For 2024,...

Alphabet Tends to Reverse or Narrow Post-Market Earnings Moves in Follow-On Regular Session

Apr 25, 2024

07:00 AM EDT, 04/25/2024 (MT Newswires) -- Alphabet (GOOGL, GOOG) is due with its Q1 results in the after-hours today. Analysts polled by Capital IQ expect the company to post a profit of $1.50 per share on revenue of $78.7 billion. GOOGL has recorded an earnings-driven after-hours decline in 32 of the last 78 quarters we've tracked, and in 14...